Research Paper Volume 14, Issue 4 pp 1879—1890
Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
Figure 3. Survival of HCC patients with different Gal-9 mRNA levels from the GEPIA database. (http://gepia.cancer-pku.cn/; Cutoff-high (%) = 10; Cutoff-low (%) = 90). HCC patients with high Gal-9 mRNA level have significantly poor survival than those with low Gal-9 mRNA level (P=0.0012).